Insider trade

CFO exercised or converted 2,475 MRNA derivative securities

Traded Jun 1, 2026 · Filed Jun 3, 2026

ModernaMRNA

2,475
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 1, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 3, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001682852-26-000115

Filed / recorded

Jun 3, 2026, 8:21 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Moderna, Inc.

Issuer CIK

1682852

Ticker

MRNA

Reporting person

James M Mock

Relationship

Officer

Officer title

Chief Financial Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Jun 1, 2026

Transaction code

M

Shares / units

2,475

Acquired / disposed

Acquired (A)

Shares owned after

60,791

Ownership form

Direct

Amendment

No

Footnotes from the filing

Restricted stock units convert into common stock on a one-for-one basis.

Around the same time

4mo ago

37KShares · @ $19.15

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

4mo ago

16KShares · @ $19.15

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold ~$2.74M of Moderna

Scheduled in advance4mo ago